Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Molecular Biology, Epidemiology, and Pathogenesis of Progressive Multifocal Leukoencephalopathy, the JC Virus-Induced Demyelinating Disease of the Human Brain.
Oxidative stress in multiple sclerosis patients in clinical remission: Association with the expanded disability status scale.
DARC shuttles inflammatory chemokines across the blood-brain barrier during autoimmune central nervous system inflammation.
[von Willebrand factor and adhesion molecules in patients with multiple sclerosis.]
Hand dexterity and direct disease related cost in multiple sclerosis.
Fingolimod (Gilenya) eligibility extended by NHS England
Are specialty drug prices destroying insurers and hurting consumers?: a number of efforts are under way to reduce price pressure.
Lymphocytosis as a response biomarker of natalizumab therapeutic efficacy in multiple sclerosis.
Erythromelalgia-like presentation of chronic acquired demyelinating polyneuropathy in a setting of past alcohol abuse.
Internal jugular vein entrapment in a multiple sclerosis patient.
Metabolite changes in radiologically isolated syndrome: More pathology than meets the eye?
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel.
Clostridia as agents of zoonotic disease.
An Overview of Models, Methods, and Reagents Developed for Translational Autoimmunity Research in the Common Marmoset (Callithrix jacchus).
Audit on intravenous immunoglobulin (ivig) use in aberdeen royal infirmary neurology department according to 2005 association of british neurologists (abn) guidelines.
AAV1.NT-3 gene therapy for Charcot-Marie-Tooth neuropathy.
Doubly selective multiple quantum chemical shift imaging and T(1) relaxation time measurement of glutathione (GSH) in the human brain in vivo.
Low serum urate levels are associated to female gender in multiple sclerosis patients.
Onabotulinum toxin A for the treatment of neurogenic detrusor overactivity due to spinal cord injury or multiple sclerosis.
Bevacizumab Diminishes Experimental Autoimmune Encephalomyelitis by Inhibiting Spinal Cord Angiogenesis and Reducing Peripheral T-Cell Responses.
Neuromyelitis optica in children: a review of the literature.
Cognitive function in multiple sclerosis: a subcortical pattern of neuropsychological impairment?
Expansion and preferential activation of the CD14(+)CD16(+) monocyte subset during multiple sclerosis.
Cervical dysplasia associated with the use of natalizumab.
[Laquinimod is an oral drug with a marked neuroprotective effect for pathogenetic treatment of multiple sclerosis(review)].

Pages